
Millions of women navigate a healthcare system that frequently misunderstands and misdiagnoses complex breast implant-related illnesses, creating a critical gap in research, care, and economic burden.
Currently living with breast implants.
Consistent with Breast Implant Illness.
For 5-25+ years, often labeled anxious or somatic.
Analyzing long-term systemic implant impact.
Approx. 2 million breast cancer survivors are implant patients, often receiving them after immune-compromising treatments.
Higher rates of delayed cancer detection due to imaging obstruction, capsular contracture, and symptoms masking recurrence.
Over 1,300 confirmed cases of BIA-ALCL globally, linked specifically to breast implants.
Average cost, almost never covered by insurance.
For misdiagnosed BII and cancer-adjacent illness.
From misdiagnosis, imaging, and unnecessary treatments.
The first platform to track BII, BIA-ALCL, and Breast Cancer as one interconnected disease environment. An AI-powered engine delivering diagnosis, data, financing, and survivorship – built for millions of women who have been invisible in the data, until now.
Born from personal battles and systemic failure, two women—Kristin Nobles and Dr. Tawana Angela Davis—ignited a revolution in women's health. They built the world's first AI-powered clinical research and diagnostic engine for breast implant-related illness, autoimmune disease, and emerging implant-associated cancers.
Breast Implant Illness affects over 20 million women worldwide, leading to chronic misdiagnosis, severe health decline, and life-threatening cancers. This widespread suffering, ignored by traditional healthcare, became the urgent call to action for our founders.
Kristin and Dr. Tawana formed a groundbreaking infrastructure, uniting survivor truth, academic rigor, AI innovation, and community healing. Their vision: to create a system that could finally diagnose, protect, and support millions.
They then built an unparalleled team of experts, including Christine Torres, Dr. Theresa Ashby, Dan Witzling, Dirk Armbrust, Dublin Wahlberg, and Chandra Challagonda. This collective brings legal insight, AI strategy, storytelling power, and enterprise governance, committed to reforming women's healthcare from the ground up.
What we are designing is not merely a product; it’s a powerful new infrastructure capable of achieving what institutions would not—a future where millions of women are diagnosed, protected, and supported.
Study the real impact of breast implants and related conditions
Build the first AI-driven, peer-reviewed clinical trial platform for the breast health triad
Protect and empower patients with data, not gaslighting
We sit at the intersection of:
Patients & Survivors
the ones who've lived this
Clinicians & Researchers
the ones ready to do the work
Technologists
the ones building the AI engine
Donors, Sponsors & Impact Investors
the ones who understand that health equity is the smartest investment on the planet
And yes, we are proudly connected to SickTitties.org – the media and movement arm that keeps things honest, human, and impossible to ignore.
Traditional research often treats patients like data points. We treat them like co-authors.
Compare outcomes across procedures, implants, treatments, and timelines
that were invisible in siloed data
We work with open, ethical technology partners and keep patient consent, privacy, and control at the center of everything.
Our leadership team combines decades of expertise in healthcare, media, technology, and finance. Each founder brings professional excellence and personal purpose to redefine women's health through innovation, transparency, and care.
A Silicon Valley founder with 25+ years in finance, tech, and media, Kristin turned her health battle into a global movement. She leads NobleCare.ai™, an AI healthcare app, and spearheads ethical, open-source infrastructure. Her vision transforms advocacy into media and research, funding women’s health.
Minister, scholar, and human-rights advocate, Dr. Davis bridges compassion with innovation. A breast cancer thriver who also faced BII, she brings vital personal insight and operational leadership. She ensures empathy and equity are central, shaping our unified, community-driven care ecosystem.
An award-winning producer, former prosecutor, and media strategist, Christine brings truth and accountability. Her background from Law & Order to global impact campaigns ensures our narratives are accurate, ethical, and rooted in lived experience, driving advocacy into global awareness.
Co-Founder of B Noble Impact Accelerator, Dirk has been integral to our mission from the start. An experienced M&A advisor, he ensures every dollar translates into measurable impact. His expertise helps transform our bold vision into a viable, scalable, and self-sustaining enterprise.
United by purpose and powered by technology, our team is rewriting the story of women’s health—one breakthrough at a time.
Our esteemed Advisory Board comprises leaders from diverse fields, bringing a wealth of experience to guide our strategic direction and ensure our mission's success.
A seasoned public health and nonprofit executive, Dan brings extensive experience in enterprise strategy, fintech innovation, and digital health. His background includes leadership roles at Bioscience Los Angeles County Inc. and the American Cancer Society. Dan advises on critical areas such as capital systems, payer-model innovation, and health infrastructure partnerships, ensuring our financial and operational strategies align with maximum impact.
Writer, actor, producer, and angel investor, Dublin drives impact through storytelling and advocacy. As an advisor and executive producer, he curates events and campaigns, amplifying awareness for women’s health. His artistic insight and business discipline embody our commitment to real-world change.
Each member is deeply committed to revolutionizing women's breast health through ethical innovation and strategic leadership.
We're eager to connect with patients, researchers, technologists, and partners who share our vision for a healthier future in women's breast health.
For questions about NobleCare AI Research Group, supporting our research or general information:
Interested in collaborating on events fundraisers or media inquiries?
Follow us on social media for updates and community engagement.
\